230 related articles for article (PubMed ID: 16623654)
1. Long-term outcomes of stimulant medication in attention-deficit hyperactivity disorder.
Poulton A
Expert Rev Neurother; 2006 Apr; 6(4):551-61. PubMed ID: 16623654
[TBL] [Abstract][Full Text] [Related]
2. Impact of comorbid autism spectrum disorders on stimulant response in children with attention deficit hyperactivity disorder: a retrospective and prospective effectiveness study.
Santosh PJ; Baird G; Pityaratstian N; Tavare E; Gringras P
Child Care Health Dev; 2006 Sep; 32(5):575-83. PubMed ID: 16919137
[TBL] [Abstract][Full Text] [Related]
3. Evolution of the treatment of attention-deficit/hyperactivity disorder in children: a review.
Findling RL
Clin Ther; 2008 May; 30(5):942-57. PubMed ID: 18555941
[TBL] [Abstract][Full Text] [Related]
4. The relationship between tourette syndrome, attention deficit hyperactivity disorder, and stimulant medication: a critical review.
Erenberg G
Semin Pediatr Neurol; 2005 Dec; 12(4):217-21. PubMed ID: 16780292
[TBL] [Abstract][Full Text] [Related]
5. Effect of stimulant medications for attention-deficit/hyperactivity disorder on later substance use and the potential for stimulant misuse, abuse, and diversion.
Faraone SV; Wilens TE
J Clin Psychiatry; 2007; 68 Suppl 11():15-22. PubMed ID: 18307377
[TBL] [Abstract][Full Text] [Related]
6. Growth on stimulant medication; clarifying the confusion: a review.
Poulton A
Arch Dis Child; 2005 Aug; 90(8):801-6. PubMed ID: 16040876
[TBL] [Abstract][Full Text] [Related]
7. Emergence of tics in children with attention deficit hyperactivity disorder treated with stimulant medications.
Varley CK; Vincent J; Varley P; Calderon R
Compr Psychiatry; 2001; 42(3):228-33. PubMed ID: 11349243
[TBL] [Abstract][Full Text] [Related]
8. Cardiac safety of central nervous system stimulants in children and adolescents with attention-deficit/hyperactivity disorder.
Winterstein AG; Gerhard T; Shuster J; Johnson M; Zito JM; Saidi A
Pediatrics; 2007 Dec; 120(6):e1494-501. PubMed ID: 18055666
[TBL] [Abstract][Full Text] [Related]
9. Effects of long-term psychostimulant medication on growth of children with ADHD.
Zachor DA; Roberts AW; Hodgens JB; Isaacs JS; Merrick J
Res Dev Disabil; 2006; 27(2):162-74. PubMed ID: 15955659
[TBL] [Abstract][Full Text] [Related]
10. Attention-deficit-hyperactivity disorder: an update.
Dopheide JA; Pliszka SR
Pharmacotherapy; 2009 Jun; 29(6):656-79. PubMed ID: 19476419
[TBL] [Abstract][Full Text] [Related]
11. Symptoms of attention-deficit/hyperactivity disorder following traumatic brain injury in children.
Levin H; Hanten G; Max J; Li X; Swank P; Ewing-Cobbs L; Dennis M; Menefee DS; Schachar R
J Dev Behav Pediatr; 2007 Apr; 28(2):108-18. PubMed ID: 17435461
[TBL] [Abstract][Full Text] [Related]
12. Growth and sexual maturation in children and adolescents with attention deficit hyperactivity disorder.
Poulton A
Curr Opin Pediatr; 2006 Aug; 18(4):427-34. PubMed ID: 16914999
[TBL] [Abstract][Full Text] [Related]
13. Growth deficits in children with attention deficit hyperactivity disorder.
Spencer T; Biederman J; Wilens T
Pediatrics; 1998 Aug; 102(2 Pt 3):501-6. PubMed ID: 9685453
[TBL] [Abstract][Full Text] [Related]
14. Modifiers of long-term school outcomes for children with attention-deficit/hyperactivity disorder: does treatment with stimulant medication make a difference? Results from a population-based study.
Barbaresi WJ; Katusic SK; Colligan RC; Weaver AL; Jacobsen SJ
J Dev Behav Pediatr; 2007 Aug; 28(4):274-87. PubMed ID: 17700079
[TBL] [Abstract][Full Text] [Related]
15. Stimulant medications.
Greenhill LL; Halperin JM; Abikoff H
J Am Acad Child Adolesc Psychiatry; 1999 May; 38(5):503-12. PubMed ID: 10230181
[TBL] [Abstract][Full Text] [Related]
16. Attention-deficit/hyperactivity disorder: are we medicating for social disadvantage? (Against).
Efron D
J Paediatr Child Health; 2006 Sep; 42(9):548-51. PubMed ID: 16925543
[TBL] [Abstract][Full Text] [Related]
17. Two-year outcome of treatment with central stimulant medication in adult attention-deficit/hyperactivity disorder: a prospective study.
Bejerot S; Rydén EM; Arlinde CM
J Clin Psychiatry; 2010 Dec; 71(12):1590-7. PubMed ID: 20584517
[TBL] [Abstract][Full Text] [Related]
18. Advances and considerations in attention-deficit/hyperactivity disorder pharmacotherapy.
Mohammadi M; Akhondzadeh S
Acta Med Iran; 2011; 49(8):487-98. PubMed ID: 22009816
[TBL] [Abstract][Full Text] [Related]
19. Bulimia nervosa and attention deficit hyperactivity disorder: a possible role for stimulant medication.
Dukarm CP
J Womens Health (Larchmt); 2005 May; 14(4):345-50. PubMed ID: 15916509
[TBL] [Abstract][Full Text] [Related]
20. The reinforcing effects of nicotine and stimulant medication in the everyday lives of adult smokers with ADHD: A preliminary examination.
Gehricke JG; Whalen CK; Jamner LD; Wigal TL; Steinhoff K
Nicotine Tob Res; 2006 Feb; 8(1):37-47. PubMed ID: 16497598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
